Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Tual-Chalot

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 14, 2021
MicroRNA-based therapy of postmyocardial infarction heart failureSimon Tual-Chalot, Konstantinos Stellos
Cardiovascular Research|April 13, 2022
Targeting the adipose tissue: heart crosstalk in pressure overload-induced heart failureSimon Tual-Chalot, Konstantinos Stellos
European Heart Journal|May 30, 2025
Unravelling heart failure cellular signalling heterogeneity with spatial transcriptomicsSimon Tual-Chalot, Konstantinos Stellos
European Heart Journal|July 13, 2021
Drug repurposing to prevent pressure overload-induced cardiac hypertrophy and heart failureSimon Tual-Chalot, Konstantinos Stellos
Cardiovascular Research|March 30, 2024
First-in-human gene editing for lipid lowering: the initial resultsSimon Tual-Chalot, Konstantinos Stellos
Cardiovascular Research|June 14, 2020
Therapeutic potential of adenosine kinase inhibition in vascular diseaseSimon Tual-Chalot, Konstantinos Stellos
European Heart Journal|March 10, 2022
Chrono-pharmacology-based antiplatelet therapy for acute myocardial infarctionSimon Tual-Chalot, Konstantinos Stellos
Cardiovascular Research|June 27, 2025
Targeting autophagy to treat neointimal hyperplasia in vascular diseaseRunan Yan, Simon Tual-Chalot, Konstantinos Stellos
European Heart Journal|April 26, 2024
Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injuryMichael Amponsah-Offeh, Simon Tual-Chalot, Konstantinos Stellos
Frontiers in Genetics|March 6, 2015
Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challengesSimon Tual-Chalot, S Paul Oh, Helen M Arthur
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 14, 2021
MicroRNA-based therapy of postmyocardial infarction heart failureSimon Tual-Chalot, Konstantinos Stellos
Cardiovascular Research|April 13, 2022
Targeting the adipose tissue: heart crosstalk in pressure overload-induced heart failureSimon Tual-Chalot, Konstantinos Stellos
European Heart Journal|May 30, 2025
Unravelling heart failure cellular signalling heterogeneity with spatial transcriptomicsSimon Tual-Chalot, Konstantinos Stellos
European Heart Journal|July 13, 2021
Drug repurposing to prevent pressure overload-induced cardiac hypertrophy and heart failureSimon Tual-Chalot, Konstantinos Stellos
Cardiovascular Research|March 30, 2024
First-in-human gene editing for lipid lowering: the initial resultsSimon Tual-Chalot, Konstantinos Stellos
Cardiovascular Research|June 14, 2020
Therapeutic potential of adenosine kinase inhibition in vascular diseaseSimon Tual-Chalot, Konstantinos Stellos
European Heart Journal|March 10, 2022
Chrono-pharmacology-based antiplatelet therapy for acute myocardial infarctionSimon Tual-Chalot, Konstantinos Stellos
Cardiovascular Research|June 27, 2025
Targeting autophagy to treat neointimal hyperplasia in vascular diseaseRunan Yan, Simon Tual-Chalot, Konstantinos Stellos
European Heart Journal|April 26, 2024
Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injuryMichael Amponsah-Offeh, Simon Tual-Chalot, Konstantinos Stellos
Frontiers in Genetics|March 6, 2015
Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challengesSimon Tual-Chalot, S Paul Oh, Helen M Arthur
Pageof 7